Nvidia, AMD to pay 15% of China chip sales revenue to US govt- FT
Investing.com - Canaccord Genuity has reduced its price target on Helen of Troy (NASDAQ:HELE) to $47.00 from $53.00 while maintaining a Buy rating on the stock. The company, currently trading at $32.66 with a market capitalization of $750 million, shows a notably low P/E ratio of 5.3x, according to InvestingPro data.
The price target adjustment comes as the investment firm anticipates lower earnings as higher-tariff products flow through the company’s profit and loss statement in the near term. Canaccord also noted uncertainty surrounding Helen of Troy’s strategy following a recent CEO change. Despite these challenges, InvestingPro analysis indicates the company maintains a GOOD overall financial health score, with liquid assets exceeding short-term obligations.
The consumer goods company has faced significant challenges from tariff uncertainties and a challenging consumer macroeconomic environment affecting its discretionary brands. Adding to investor concerns, Helen of Troy did not provide guidance during a period when the market sought clarity, followed by a management transition.
Despite these headwinds, Canaccord believes the tariff situation is becoming clearer, with China tariffs expected to be approximately 54% rather than the previously feared 145%, while Vietnam tariffs are settling around 20% instead of a potential 46%.
With Helen of Troy trading below 6 times FY2 earnings, 7 times EBITDA, and under 1 times sales, Canaccord maintains that the valuation "remains compelling" and sees potential upside as tariff clarity improves and sales stabilization becomes more visible. According to InvestingPro’s Fair Value analysis, the stock appears significantly undervalued at current levels, with 12 additional ProTips available for subscribers.
In other recent news, Helen of Troy has reported its fourth-quarter earnings for fiscal year 2025, revealing mixed results. The company recorded earnings per share (EPS) of $2.33, slightly below the forecast of $2.39, while revenue surpassed expectations at $485.9 million, compared to the anticipated $482.24 million. The company’s performance was impacted by a 0.7% decrease in net sales and a significant drop in operating margin to 0.4% from 13.5% the previous year. Looking ahead, Helen of Troy has not provided formal guidance for fiscal 2026 due to trade policy uncertainties and potential tariff impacts, which are expected to cost over $200 million. UBS has maintained a Neutral rating on Helen of Troy, lowering the price target from $34.00 to $32.00, ahead of the company’s upcoming first-quarter earnings report. UBS forecasts an EPS of $0.97, slightly above the consensus estimate of $0.94. The firm notes that top-line visibility remains a key concern, suggesting limited investor willingness to invest in Helen of Troy at this stage.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.